Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 281
Indoor Allergens: Assessing and Controlling Adverse Health Effects Acronyms ABPA allergic bronchopulmonary aspergillosis AAAI American Academy of Allergy and Immunology ACAI American College of Allergy and Immunology ACGIH American Conference of Governmental Industrial Hygienists AHU air-handling unit APC antigen-presenting cell ASHRAE American Society of Heating, Refrigerating and Air Conditioning Engineers ATSDR Agency for Toxic Substances and Disease Registry BAL bronchoalveolar lavage BRI building-related illness CBER Center for Biologics Evaluation and Research CTL cytolytic T lymphocytes ELISA enzyme-linked immunosorbent assay EPA U.S. Environmental Protection Agency FDA U.S. Food and Drug Administration FEF forced expiratory flow FEF25–75 forced expiratory flow between 25 and 75 percent of forced vital capacity
OCR for page 282
Indoor Allergens: Assessing and Controlling Adverse Health Effects FEV1 forced expiratory volume exhaled in 1 second FVC forced vital capacity GM-CSF granulocyte macrophage colony stimulating factor HEPA filter high-efficiency particulate arresting filter HETES hydroxyeicosatetraenoic acids HIV human immunodeficiency virus HMW high molecular weight HP hypersensitivity pneumonitis HVAC system heating, ventilation, and air conditioning system IFN interferon Ig immunoglobulin IgE immunoglobulin E IL-1 interleukin-1 IUIS International Union of Immunologic Societies kDa kilodalton (molecular mass measure) LMW low molecular weight LOAEL lowest observed adverse effect level LRSS late respiratory systemic syndrome MCS multiple chemical sensitivity MHC major histocompatibility complex NAAQS National Ambient Air Quality Standards NHLBI National Heart, Lung, and Blood Institute NIAID National Institute of Allergy and Infectious Disease NIEHS National Institute of Environmental Health Sciences NIH National Institutes of Health NIOSH National Institute for Occupational Safety and Health NOAEL no observed adverse effect level OSHA Occupational Safety and Health Administration OTA Office of Technology Assessment OTS Office of Toxic Substances PAF platelet-activating factor PDA pulmonary disease anemia PEL permissible exposure limit PG prostaglandin
OCR for page 283
Indoor Allergens: Assessing and Controlling Adverse Health Effects PMN polymorphonuclear leukocyte ppb parts per billion ppm parts per million RAST radioallergosorbent test SBS sick (or tight) building syndrome TLV threshold limit value TMA trimellitic anhydride TM-HSA trimellitic anhydride conjugated with human serum albumin UF uncertainty factor WHO World Health Organization
Representative terms from entire chapter: